129 related articles for article (PubMed ID: 12947541)
1. [The role of the glutamatergic system in alcohol addiction].
Spanagel R
Fortschr Neurol Psychiatr; 2003 Jul; 71 Suppl 1():S33-5. PubMed ID: 12947541
[TBL] [Abstract][Full Text] [Related]
2. Drugs for relapse prevention of alcoholism: ten years of progress.
Spanagel R; Kiefer F
Trends Pharmacol Sci; 2008 Mar; 29(3):109-15. PubMed ID: 18262663
[TBL] [Abstract][Full Text] [Related]
3. [Glutamatergic mechanisms in alcohol dependence--genetic, molecular-biological and neuropharmacological findings].
Soyka M; Preuss U
Fortschr Neurol Psychiatr; 2003 Jul; 71 Suppl 1():S45-50. PubMed ID: 12947543
[TBL] [Abstract][Full Text] [Related]
4. The role of the NMDA receptor in alcohol relapse: a pharmacological mapping study using the alcohol deprivation effect.
Vengeliene V; Bachteler D; Danysz W; Spanagel R
Neuropharmacology; 2005 May; 48(6):822-9. PubMed ID: 15829254
[TBL] [Abstract][Full Text] [Related]
5. [Excitatory neurotransmission in alcoholism].
Bleich S; Sperling W; Wiltfang J; Maler JM; Kornhuber J
Fortschr Neurol Psychiatr; 2003 Jul; 71 Suppl 1():S36-44. PubMed ID: 12947542
[TBL] [Abstract][Full Text] [Related]
6. The role of glutamatergic neurotransmission in the pathophysiology of alcoholism.
Tsai G; Coyle JT
Annu Rev Med; 1998; 49():173-84. PubMed ID: 9509257
[TBL] [Abstract][Full Text] [Related]
7. Renaissance of NMDA receptor antagonists: do they have a role in the pharmacotherapy for alcoholism?
Nagy J
IDrugs; 2004 Apr; 7(4):339-50. PubMed ID: 15057640
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacological treatment options for prevention of alcohol relapse].
Heberlein A; Bleich S; Kornhuber J; Hillemacher T
Fortschr Neurol Psychiatr; 2008 Jul; 76(7):421-8. PubMed ID: 18604776
[TBL] [Abstract][Full Text] [Related]
9. N-methyl-D-aspartate antagonists as drug models of schizophrenia: a surprising link to tobacco smoking.
Domino EF; Mirzoyan D; Tsukada H
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Aug; 28(5):801-11. PubMed ID: 15363604
[TBL] [Abstract][Full Text] [Related]
10. Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol.
De Witte P
Addict Behav; 2004 Sep; 29(7):1325-39. PubMed ID: 15345268
[TBL] [Abstract][Full Text] [Related]
11. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
Gogas KR
Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
[TBL] [Abstract][Full Text] [Related]
12. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality.
Heresco-Levy U
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1113-23. PubMed ID: 14642971
[TBL] [Abstract][Full Text] [Related]
13. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.
Bubeníková-Valesová V; Horácek J; Vrajová M; Höschl C
Neurosci Biobehav Rev; 2008 Jul; 32(5):1014-23. PubMed ID: 18471877
[TBL] [Abstract][Full Text] [Related]
14. [The role of the glutamatergic system in pathophysiology and pharmacotherapy for depression: preclinical and clinical data].
Paslakis G; Gass P; Deuschle M
Fortschr Neurol Psychiatr; 2011 Apr; 79(4):204-12. PubMed ID: 21117011
[TBL] [Abstract][Full Text] [Related]
15. NR2A-containing NMDA receptors depress glutamatergic synaptic transmission and evoked-dopamine release in the mouse striatum.
Schotanus SM; Chergui K
J Neurochem; 2008 Aug; 106(4):1758-65. PubMed ID: 18540994
[TBL] [Abstract][Full Text] [Related]
16. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.
Javitt DC
Int Rev Neurobiol; 2007; 78():69-108. PubMed ID: 17349858
[TBL] [Abstract][Full Text] [Related]
17. Glutamate-mediated neuroplasticity in an animal model of self-injurious behaviour.
Muehlmann AM; Devine DP
Behav Brain Res; 2008 May; 189(1):32-40. PubMed ID: 18243356
[TBL] [Abstract][Full Text] [Related]
18. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
Pollandt S; Liu J; Orozco-Cabal L; Grigoriadis DE; Vale WW; Gallagher JP; Shinnick-Gallagher P
Eur J Neurosci; 2006 Sep; 24(6):1733-43. PubMed ID: 17004937
[TBL] [Abstract][Full Text] [Related]
19. Effects of low-affinity NMDA receptor channel blockers in two rat models of chronic pain.
Medvedev IO; Malyshkin AA; Belozertseva IV; Sukhotina IA; Sevostianova NY; Aliev K; Zvartau EE; Parsons CG; Danysz W; Bespalov AY
Neuropharmacology; 2004 Aug; 47(2):175-83. PubMed ID: 15223296
[TBL] [Abstract][Full Text] [Related]
20. Role of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors in the cardiovascular effects of L-glutamate microinjection into the hypothalamic paraventricular nucleus of unanesthetized rats.
Busnardo C; Tavares RF; Corrêa FM
J Neurosci Res; 2009 Jul; 87(9):2066-77. PubMed ID: 19229989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
